MoneyWorks4Me

Sanofi India informs about disclosure

13 Mar 2025 Evaluate
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi India has submitted the disclosure regarding Order issued by the Office of Customs, Excise and Service Tax Appellate Tribunal, Ahmedabad. The details of the above notice as required under Regulation 30 of Listing Regulations are enclosed.: 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..